Evaluation of biological markers for the risk assessment of carbon black in epidemiological studies
Frontiers in Public Health · 2024
DOI: 10.3389/fpubh.2024.1367797 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Public Health, 2024. Verfasst von Mei Yong und 1 weiteren Autor:innen. Beteiligte Einrichtung: MY EpiConsulting, Duesseldorf, Germany. Hauptthemen laut MEDLINE: Biomarkers, Soot, Occupational Exposure, Epidemiologic Studies. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/objectives Engineered nanomaterials (ENMs) have been suggested as being capable of promoting inflammation, a key component in the pathways associated with carcinogenesis, cardiovascular disease, and other conditions. As a result, the risk assessment of biological markers as early-stage indicators has the potential to improve translation from experimental toxicologic findings to identifying evidence in human studies. The study aims to review the possible early biological changes in workers exposed to carbon black (CB), followed by an evidentiary quality evaluation to determine the predictive value of the biological markers.
Methods
We conducted a literature search to identify epidemiological studies that assessed biological markers that were involved in the inflammatory process at early stages among workers with exposure to CB. We reviewed the studies with specific reference to the study design, statistical analyses, findings, and limitations.
Results
We identified five Chinese studies that investigated the potential impact of exposure to CB on inflammatory markers, bronchial wall thickening, genomic instability, and lung function impairment in CB production workers. Of the five Chinese studies, four were cross-sectional; another study reported results at two-time points over six years of follow-up. The authors of all five studies concluded positive relationships between exposure and the inflammatory cytokine profiles. The weak to very weak correlations between biomarkers and early-stage endpoints were reported.
Conclusion
Most inflammatory markers failed to satisfy the proposed evidentiary quality criteria. The significance of the results of the reviewed studies is limited by the cross-sectional study design, inconsistency in results, uncertain clinical relevance, and high occupational exposures. Based on this review, the risk assessment relying on inflammatory markers does not seem appropriate at this time. Nevertheless, the novel research warrants further exploration in assessing exposure to ENMs and corresponding potential health risks in occupational settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MY EpiConsulting, Duesseldorf, Germany.
- Brigham and Women's Hospital, Pulmonary Division, Harvard Medical School, Boston, MA, United States.
Zitieren
APA
Yong, M., & McCunney, R. J. (2024). Evaluation of biological markers for the risk assessment of carbon black in epidemiological studies. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2024.1367797
Vancouver
Yong M, McCunney RJ. Evaluation of biological markers for the risk assessment of carbon black in epidemiological studies. Frontiers in Public Health. 2024. doi:10.3389/fpubh.2024.1367797
BibTeX
@article{Yong2024,
author = {Yong, Mei and McCunney, Robert J},
title = {Evaluation of biological markers for the risk assessment of carbon black in epidemiological studies},
journal = {Frontiers in Public Health},
year = {2024},
doi = {10.3389/fpubh.2024.1367797}
}
EUVIMED